A recent study suggests that the dopamine D3 receptor partial agonist BP 897 prevents cocaine-seeking behavior in rats, and this may lead to new approaches to study and treat drug addiction.

L-838,417 is a partial agonist at α2, α3 and α5 subunits and ... GABA A receptor modulators as a potential new class of drugs for chronic pain.

Drug abusers. Elderly ... nalbuphine, pentazocine) or partial agonist (eg, buprenorphine); may reduce effects and/or precipitate withdrawal symptoms. Potentiated by CYP3A4 inhibitors (eg ...

Following these results, AbbVie aims to submit a new drug application (NDA ... potential of tavapadon as a first-in-class D1/D5 partial agonist for the treatment of Parkinson's disease.

Drug abusers. Renal or hepatic impairment ... nalbuphine, pentazocine) or partial agonist (eg, buprenorphine); may reduce effects and/or precipitate withdrawal symptoms. Potentiated by CYP3A4 ...

Vigil Neuroscience (NASDAQ:VIGL) announced Tuesday that the U.S. Food and Drug Administration (FDA) has removed the partial ...